Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05130866
Title Efficacy and Safety of REC-2282 in Patients With Progressive Neurofibromatosis Type 2 (NF2) Mutated Meningiomas (POPLAR-NF2)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Recursion Pharmaceuticals Inc.
Age Groups: adult | child | senior
Covered Countries USA

No variant requirements are available.